Related Experiment Videos

[Injection pain from propofol-MCT-LCT in children. A comparison with propofol-LCT]

R Larsen1, U Beerhalter, R Erdkönig

  • 1Klinik für Anästhesiologie und Intensivmedizin, Universitätskliniken des Saarlandes, Kirrbergerstrasse, 66421 Homburg/Saar. airlar@med-rz.uni-sb.de

Der Anaesthesist
|October 12, 2001
PubMed

Insights

Propofol-MCT/LCT 1% caused less injection pain and arm withdrawal in children compared to Propofol-LCT. This new formulation, Propofol-Lipuro, is superior for pediatric anesthesia induction.

Area of Science:

  • Anesthesiology
  • Pediatric Anesthesia
  • Pharmacology

Background:

  • Propofol is a widely used anesthetic agent.
  • Pain on injection is a common side effect of propofol.
  • Different propofol formulations exist, varying in their lipid emulsion composition.

Purpose of the Study:

  • To compare the incidence and intensity of injection pain between two propofol formulations in children.
  • To evaluate Propofol-MCT/LCT (Propofol-Lipuro) against Propofol-LCT (Disoprivan) for pediatric anesthesia induction.

Main Methods:

  • Prospective, randomised, double-blind study involving 40 children (aged 7-14 years).
  • Premedication with oral diazepam.
  • Induction of anesthesia involved injecting 20% of the calculated propofol dose into a dorsal hand vein.
  • Pain, spontaneous pain expression, and arm withdrawal were assessed.

Main Results:

  • Significantly fewer children reported pain with Propofol-MCT/LCT (10%) compared to Propofol-LCT (25%).
  • Significantly less arm withdrawal was observed with Propofol-MCT/LCT (10%) versus Propofol-LCT (40%).

Conclusions:

  • Propofol-MCT/LCT 1% (Propofol-Lipuro) significantly reduces injection pain and arm withdrawal in children aged 7-14 years.
  • Propofol-MCT/LCT demonstrates superior tolerability compared to Propofol-LCT for anesthesia induction in this pediatric population.
Abstract

Related Concept Videos